Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
For patent related information to plan launch of generics worldwide
— Director, international business, India
To find patent expirations in Russia
— Pharmaceutical company, Russia
For fast access to patent and market exclusivity
— Senior medical scientific advisor, Germany
To plan ahead for inventory purposes
— Pharmacy purchaser, USA
To identify possible time generic approval and launch
— Formulation research, South Korea
Generated: May 27, 2017
| Patents: | 8 |
| Tradenames: | 35 |
| Ingredients: | 30 |
| NDAs: | 35 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | DESOGEN | desogestrel; ethinyl estradiol | TABLET;ORAL-21 | 020071-001 | Dec 10, 1992 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Organon Usa Inc | ORGATRAX | hydroxyzine hydrochloride | INJECTABLE;INJECTION | 087014-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Organon Usa Inc | FOLLISTIM AQ | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021211-002 | Mar 23, 2004 | RX | Yes | Yes | 7,446,090 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Organon Usa Inc | LIQUAEMIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 000552-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Organon Usa Inc | FOLLISTIM AQ | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021211-004 | Feb 11, 2005 | RX | Yes | Yes | 7,446,090 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
For drug patent information
— Pharmaceutical business developer, USA
For patent expiration dates of brand name drugs
— Pharmacist, USA
To know what drugs are coming off patent over the next 5 years
— CRO business development manager, USA
To get a list of drugs going off patent in USA in the next few years
— Pharmaceutical sales, India
For loss of exclusivity information of drugs in Egypt, Saudi Arabia, Algeria, UAE
— Analyst, India
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
